Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Public Health (Oxford, England)|July 9, 2018
Implementation of a unique hepatitis C care continuum model in RwandaPoonam Mathur, Emily Comstock, Jean Damascene Makuza, et al.
The American Journal of Tropical Medicine and Hygiene|March 3, 2011
African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkersBenjamin Emmanuel, Esther Kawira, Martin D Ogwang, et al.
Clinical Therapeutics|September 3, 2022
Systemic Corticosteroid-related Adverse Outcomes and Health Care Resource Utilization and Costs Among Patients with Chronic Rhinosinusitis with Nasal PolyposisGreg E Davis, Robert S Zeiger, Benjamin Emmanuel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2020
DNA Methylation and Immune Cell Markers Demonstrate Evidence of Accelerated Aging in Patients with Chronic Hepatitis B Virus or Hepatitis C Virus, with or without Human Immunodeficienct Virus Co-infectionYevgeniy Gindin, Anuj Gaggar, Anna S Lok, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2026
Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE StudyNjira L Lugogo, Praveen Akuthota, Kaharu Sumino, et al.
Advances in Therapy|May 19, 2025
Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE StudyNjira L Lugogo, Praveen Akuthota, Kaharu Sumino, et al.
Hepatology International|March 6, 2019
Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patientsBenjamin Emmanuel, Samer S El-Kamary, Laurence S Magder, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 29, 2025
Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2Erika Penz, Thomas Rothe, Lieven Dupont, et al.
Journal of Hepatology|June 8, 2019
A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)Eleanor Wilson, Emily Covert, Jennifer Hoffmann, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 1, 2026
Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2Marek Lommatzsch, Erika Penz, Lieven Dupont, et al.
Pageof 6